Returning in March, the 3rd Bacteriophage Therapy Summit will discuss the characterization, pre-clinical and clinical development, formulation and manufacturing, regulation and the market delivery, this is the end-to-end specialised virtual meeting for you to translate your bacteriophage research into targeted therapeutics that demonstrate clinically significant results.We have also added a new dimension for this year's meeting with the addition of our Pre-Conference Non-Human Application Focus Daywhich will touch on the use of phages within the agricultural, livestock and food safety industries.
Conference Only - Industry (Early Bird and group discounts available): USD 1949.0,
Conference Only - Academic/Start-Up (Early Bird and group discounts available): USD 1499.0
Speakers: Sailaja Puttagunta, CMO, BiomX, Steven Theriault, CEO and CSO, Cytophage, Xavier Duportet, Co-Founder and CEO, Eligo Bioscience, Cara Fiore, Microbiologist, FDA, Office of Vaccines Research and Review, Danish Malik, Reader Industrial Biology, Loughborough University, Saima Aslam, Associate Professor, Division of Infectious Diseases and Global Public Health, iPATH - Center for Innovative Phage Applications and Therapeutics, and more!
Time: 08:00 - 17:00